Association of Short and Long Sleep Duration With Amyloid-β Burden and Cognition in Aging
Authors: Joseph R. Winer, Kacie D. Deters, Gabriel Kennedy, Meghan Jin, Andrea Goldstein-Piekarski, Kathleen L. Poston, Elizabeth C. Mormino
Journal: JAMA Neurology (2021)

<h3>Importance</h3> Disrupted sleep is common in aging and is associated with cognition. Age-related changes to sleep are associated with multiple causes, including early Alzheimer disease pathology (amyloid β [Aβ]), depression, and cardiovascular disease. <h3>Objective</h3> To investigate the associations between self-reported sleep duration and brain Aβ burden as well as the demographic, cognitive, and lifestyle variables in adults with normal cognition. <h3>Design, Setting, and Participants</h3> This cross-sectional study obtained data from participants in the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) study, which is being conducted in 67 sites in the United States, Canada, Australia, and Japan. The sample for this analysis consisted of individuals aged 65 to 85 years who underwent an Aβ positron emission tomography (PET) scan, had complete apolipoprotein E (<i>APOE</i>) genotype data, and were identified as clinically normal (per a Clinical Dementia Rating score of 0) and cognitively unimpaired (per a Mini-Mental State Examination score of 25 to 30 and Logical Memory Delayed Recall test score of 6 to 18). Data were analyzed from April 3, 2020, to June 20, 2021. <h3>Main Outcomes and Measures</h3> The outcome was self-reported nightly sleep duration (grouped by short sleep duration: ≤6 hours, normal sleep duration: 7-8 hours, and long sleep duration: ≥9 hours) compared with demographic characteristics, Aβ burden (as measured with a fluorine 18–labeled-florbetapir PET scan), objective and subjective cognitive function measures, and lifestyle variables. <h3>Results</h3> The 4417 participants in the study included 2618 women (59%) and had a mean (SD) age of 71.3 (4.7) years. Self-reported shorter sleep duration was linearly associated with higher Aβ burden (β [SE] = –0.01 [0.00];<i>P</i> = .005), and short sleep duration was associated with reduced cognition that was mostly in memory domains. No difference in Aβ was found between long and normal sleep duration groups (β [SE] = 0.00 [0.01];<i>P</i> = .99). However, compared with normal sleep duration, both short and long sleep durations were associated with higher body mass index (short vs normal sleep duration: β [SE] = 0.48 [0.17],<i>P</i> = .01; long vs normal sleep duration: β [SE] = 0.97 [0.31],<i>P</i> = .002), depressive symptoms (short vs normal sleep duration: β [SE] = 0.31 [0.05],<i>P</i> &lt; .001; long vs normal sleep duration: β [SE] = 0.39 [0.09],<i>P</i> &lt; .001), and daytime napping (short vs normal sleep duration: β [SE] = 2.66 [0.77],<i>P</i> = .001; long vs normal sleep duration: β [SE] = 3.62 [1.38],<i>P</i> = .01). Long sleep duration was associated with worse performance across multiple cognitive domains. <h3>Conclusions and Relevance</h3> In this cross-sectional study, both short and long sleep durations were associated with worse outcomes for older adults, such as greater Aβ burden, greater depressive symptoms, higher body mass index, and cognitive decline, emphasizing the importance of maintaining adequate sleep.